Quinazoline antifolates inhibiting thymidylate synthase: 4-thio-substituted analogues
- PMID: 2002476
- DOI: 10.1021/jm00107a015
Quinazoline antifolates inhibiting thymidylate synthase: 4-thio-substituted analogues
Abstract
We report the synthesis of four new 4-thio-5,8-dideazafolic acid analogues and a 4-(methylthio) analogue structurally related to the thymidylate synthase (TS) inhibitor N10-propargyl-5,8-dideazafolic acid. Three N10-propargyl-4-thio-5,8-dideazafolic acid analogues had C2 amino, hydrogen, and methyl substituents. A 4-thio and a 4-(methylthio) compound each with hydrogen at C2 and ethyl at N10 were also synthesized. In general, the synthetic route involved thionation of the appropriate 4-oxoquinazoline; the sulfur thus introduced was then protected by methylation. Further protection with a pivaloyl group was required for the quinazoline bearing a 2-amino substituent. The protected quinazolines were treated with N-bromosuccinimide and the resulting 6-(bromomethyl) compounds were then coupled to the appropriate N-monoalkylated diethyl N-(4-aminobenzoyl)-L-glutamate in N,N-dimethylacetamide with calcium carbonate as base. The 4-thio-5,8-dideazafolic acids were obtained by removal of the methylthio group with sodium hydrosulfide, followed by deprotection of the carboxyl groups with cold dilute alkali. For the compound containing a pivaloyl protecting group, hot dilute alkali was used. To obtain the 5,8-dideazafolic acid containing a 4-(methylthio) substituent, the corresponding diester was treated with lithium hydroxide which selectively deprotected the carboxyl groups. The five compounds were tested as inhibitors of L1210 TS. It was found that replacement of the 4-oxygen of the quinazoline moiety by sulfur did not alter the TS inhibition. However, the introduction of a methylthio substituent at position 4 severely impaired TS inhibition. All 4-thio compounds were less cytotoxic to L1210 cells in culture than their 4-oxo counterparts.
Similar articles
-
Quinazoline antifolate thymidylate synthase inhibitors: nitrogen, oxygen, sulfur, and chlorine substituents in the C2 position.J Med Chem. 1989 Mar;32(3):569-75. doi: 10.1021/jm00123a010. J Med Chem. 1989. PMID: 2918503
-
Quinazoline antifolates inhibiting thymidylate synthase: 2-desamino derivatives with enhanced solubility and potency.J Med Chem. 1989 Apr;32(4):847-52. doi: 10.1021/jm00124a018. J Med Chem. 1989. PMID: 2704030
-
Quinazoline antifolate thymidylate synthase inhibitors: 2'-fluoro-N10-propargyl-5,8-dideazafolic acid and derivatives with modifications in the C2 position.J Med Chem. 1990 Nov;33(11):3067-71. doi: 10.1021/jm00173a025. J Med Chem. 1990. PMID: 2231607
-
Folate-based thymidylate synthase inhibitors as anticancer drugs.Ann Oncol. 1995 Nov;6(9):871-81. doi: 10.1093/oxfordjournals.annonc.a059353. Ann Oncol. 1995. PMID: 8624289 Review.
-
Nonpolyglutamatable antifolates as inhibitors of thymidylate synthase (TS) and potential antitumour agents.Curr Med Chem. 1998 Aug;5(4):265-88. Curr Med Chem. 1998. PMID: 9668195 Review.
Cited by
-
Modular synthesis of clickable peptides via late-stage maleimidation on C(7)-H tryptophan.Nat Commun. 2023 Jul 5;14(1):3973. doi: 10.1038/s41467-023-39703-y. Nat Commun. 2023. PMID: 37407547 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Chemical Information
Medical
Miscellaneous